Rhythm Biosciences Ltd (ASX:RHY) Reports Strong Quarterly Results
Rhythm Biosciences Ltd (ASX:RHY) announces significant quarterly achievements including funding, strategic acquisitions, and product developments.
Rhythm Biosciences Ltd (ASX:RHY) announces significant quarterly achievements including funding, strategic acquisitions, and product developments.
EZZ Life Science Holdings reported strong Q2 FY25 results, showcasing significant revenue growth and a strategic outlook for future market expansion.
Praemium Limited (ASX:PPS) reports a 29% increase in FUA to $62.1 billion, highlighting strong growth metrics and inflows for Q2 FY2025.
Contact Energy secures a long-term gas supply contract, enhancing its operational capabilities and supporting its energy transition strategies.
Iceni Gold (ASX: ICL) announces significant expansion of the Guyer gold anomaly following the fourth aircore drill campaign at the 14 Mile Well Gold Project.
Credit Intelligence Limited (ASX:CI1) has issued a profit warning, projecting a loss for the half-year ending 31 December 2024.
NuEnergy Gas Limited (ASX:NGY) announces its quarterly cash flow results, detailing a net cash outflow and ongoing financing arrangements.
Chrysos Corporation (ASX:C79) reports strong growth in Q2 FY25, with 12% revenue growth and robust international expansion.
Anax Metals (ASX: ANX) has applied for a new exploration license, expanding its footprint in the Pilbara region.
Spectur Limited (ASX:SP3) reports a net cash increase for the quarter, with significant operational revenue growth despite ongoing expenditures.